Nishimoto, Yuji
,
Yamashita, Yugo
Morimoto, Takeshi
Saga, Syunsuke
Amano, Hidewo
Takase, Toru
Hiramori, Seiichi
Kim, Kitae
Oi, Maki
Akao, Masaharu
Kobayashi, Yohei
Toyofuku, Mamoru
Izumi, Toshiaki
Tada, Tomohisa
Chen, Po-Min
Murata, Koichiro
Tsuyuki, Yoshiaki
Sasa, Tomoki
Sakamoto, Jiro
Kinoshita, Minako
Togi, Kiyonori
Mabuchi, Hiroshi
Takabayashi, Kensuke
Shiomi, Hiroki
Kato, Takao
Makiyama, Takeru
Ono, Koh
Sato, Yukihito
Kimura, Takeshi
Article History
Received: 21 June 2018
Accepted: 28 September 2018
First Online: 6 October 2018
Conflicts of interest
: Dr. Yamashita received lecture fees from Daiichi-Sankyo, Bristol-Myers Squibb, and Bayer Healthcare. Dr. Morimoto received lecture fees from Mitsubishi Tanabe Pharma and Pfizer Japan and consultant fees from Asahi Kasei, Bristol-Myers Squibb, and Boston Scientific. Dr. Akao received lecture fees from Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Bayer Healthcare and Daiichi-Sankyo. Dr. Kimura serves as an advisory board member for Abbott Vascular and Terumo Company. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.